Journals / Uluslararası Hematoloji-Onkoloji Dergisi / 2010 / Cilt: 20 - Sayı: 2

Ailesel epidermodisplazia verrusiformis zemininde gelişen agresif yassı hücreli cilt kanseri: Bir ailede üç olgu

Aggressive squamous cell carcinoma developed on familial epidermodysplasia verruciformis basis: Three cases in a family

Pages
122–124
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Three members of a family (two daughters and a son) with squamous cell carcinoma developed on epidermodisplasia verruciformis basis and treatment modalities are reported here.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Epidermodyplasia Verruciformis is a rare genetic disease, which is usually inherited in an automosal recessive manner.
📊
Key Findings & Data:Intraepithelial neoplasia should be treated with CO2 laser therapy, photodynamic therapy or imiguimod.
💡
Conclusion & Impact:Three members of a family (two daughters and a son) with squamous cell carcinoma developed on epidermodisplasia verruciformis basis and treatment modalities are reported here.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Epidermodyplasia Verruciformis is a rare genetic disease, which is usually inherited in an automosal recessive manner. Flat, papular and macular skin lesions generally occur at the dorsal side of the hands, extremities and face at childhood due to defect of cell mediated immunity. These macular lesions progress to intraepithelial lesions and skin malignancies such as squamous cell carcinoma. It can also be seen in immune deficiency. It may be related to the sporadic gene mutations. Suspicious premalignant and malignant lesions should be resected with negative surgical margin. Patients and their relatives with suspicious lesions should be protected from sun exposure and followed up carefully. Intraepithelial neoplasia should be treated with CO2 laser therapy, photodynamic therapy or imiguimod. Three members of a family (two daughters and a son) with squamous cell carcinoma developed on epidermodisplasia verruciformis basis and treatment modalities are reported here.

Özet

Epidermodisplazia verrusiformis otozomal ressesif geçiş gösteren nadir bir genetik hastalıktır. Hücresel bağışıklık sistemindeki bozukluk nedeniyle çocukluk çağında el sırtında, ekstremitelerde ve yüzde papüler ve maküler lezyonlar oluşmaya başlar. Maküler lezyonlar zamanla intraepitelyal lezyonlara ve özellikle güneş gören bölgelerde yassı hücreli cilt kanseri gibi malignitelere dönüşebilir. ‹mmun yetmezlik durumlarında görülebildiği gibi sporadik gen mutasyonları ile de ilişkili olabilir. fiüpheli premalign ve malign lezyonların geniş eksizyonları gereklidir. Hastalar ve şüpheli lezyonları olan yakınları, güneşten korunmalı ve sık aralıklarla takip edilmelidirler. ‹ntraepitelyal neoplaziler fotodinamik tedavi, CO2 lazer veya imiguimod ile de tedavi edilebilirler. Burada üç cocuklu bir ailede tüm kardeşlerde (iki kız ve bir oğlan) görülen ailesel Epidermodisplazia Verrusiformis zemininde gelişen yassı hücreli cilt kanseri ve tedavi modaliteleri sunulmuştur.

🔖

Cite This Article

DOĞAN, L., KARAMAN, N., YILMAZ, K. B., MARKOÇ, F., ATALAY, C., ÖZASLAN, C. (2010). Ailesel epidermodisplazia verrusiformis zemininde gelişen agresif yassı hücreli cilt kanseri: Bir ailede üç olgu. Uluslararası Hematoloji-Onkoloji Dergisi, Cilt: 20 - Sayı: 2, 122–124. https://ajindex.com/articles/323219

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Jablonska S, Majevski S. Epidermodysplasia verruciformis: Immunological and clinical aspects. Curr Top Microbiol Immunol 186: 157-175, 1994
  2. Lutzner MA. Epidermodysplasia verruciformis. An autosomal recessive disease characterized by viral warts and skin cancer. A model for viral oncogenesis. Bull Cancer 65: 169-182, 1978
  3. Ramoz N, Taieb A, Ruenda L. Evidence for a nonallelic heterogeneity of epidermodysplasia verruciformis with two susceptibility loci mapped to chromosome regions 2p21-p24 and 17q25. J Invest Dermatol 114: 1148-1153, 2000
  4. Ramoz N, Ruenda LA, Bouadjar B. Mutations in two adjacent novel genes are associated with epidermodysplasia verruciformis. Nat Genet 32: 579-581, 2002
  5. Ramoz N, Ruenda LA, Bouadjar B. A susceptibility locus for epidermodysplasia verruciformis, an abnormal predisposition to infection with the oncogenic human papillomavirus type 5, maps to chromosome 17qter in a region containing a psoriasis locus. J Invest Dermatol 112: 259-263, 1999
  6. Deau MC, Favre M, Orth G. Genetic heterogeneity among human papillomaviruses (HPV) associated with epidermodysplasia verruciformis: Evidence for multiple allelic forms of HPV5 and HPV8 E6 genes. Virology 184: 492-503, 1991
  7. Majewski S, Jablonska S. Why epidermodysplasia verruciformis - A rare genetic disease - has raised such great interest. Int J Dermatol 43: 309-311, 2004
  8. Gül U, K›l›ç A, Gönül M, Külcü S. Clinical aspects of epidermodysplasia verruciformis and review of the literature. Int J Dermatol 46: 1069-1072, 2007
  9. Harris AJ, Purdie K, Leigh IM. A novel human papillomavirus identified in epidermodysplasia verruciformis. Br J Dermatol 136: 587-591, 1997
  10. Lutzner MA, Blanchet-Bardon C. Epidermodysplasia verruciformis. Curr Probl Dermatol 13: 164-185, 1985
  11. Garcia-Rio I, Garcio-F-Villalta MJ, Dauden E. Epidermodysplasia verruciformis-like lesions in a patient with systemic lupus erythematosus. Acta Derm Venereol 83: 229-230, 2003
  12. Karrer S, Szeimies RM, Abels C. Epidermodysplasia verruciformis treated using topical 5-aminolaevulinic acid photodynamic therapy. Br J Dermatol 140:935-938, 1999.